World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases

SRN Advisors, LLC Announces Changes to Investment Objective, Principal Investment Strategies and Name for the Siren Nasdaq NexGen Economy ETF (BLCN)

Cision PR Newswire by Cision PR Newswire
December 19, 2025
in Press Releases
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

HUNTINGDON VALLEY, Pa., Dec. 19, 2025 /PRNewswire/ — SRN Advisors, LLC (SRN) announced today that, effective as of December 29, 2025 (the “Effective Date”), the Siren Nasdaq NexGen Economy ETF (BLCN) (the “Fund”) will implement a new investment objective and new principal investment strategies and adopt a new name.

The Fund currently has an investment objective to seek long-term growth by tracking the investment returns, before fees and expenses, of the Nasdaq Blockchain Economy Index and currently employs a passive investment strategy designed to achieve this objective. Effective as of the Effective Date:

  • The Fund’s investment objective will change to seeking long-term capital appreciation.
  • The Fund will employ an actively-managed investment strategy.
  • The Fund’s name will change to the Siren NexGen Economy ETF.

Investors should review the Fund’s updated Prospectus and Summary Prospectus for additional information.

About SRN Advisors, LLC

SRN is an ETF sponsor and investment adviser. SRN seeks to identify companies that can be put into ETF portfolios designed to give retail and institutional investors key, focused opportunities, with the continued goal of lower costs than the peer universe.

Carefully consider the Fund’s investment objective, risks, charges and expenses before investing. For this and other important information, obtain a statutory prospectus by calling 866-829-5457 or visiting www.sirenetfs.com.

An investment in the Fund is subject to investment risk, including the possible loss of principal. Fund shares may be bought and sold on an exchange through a brokerage account. Brokerage commissions and expenses will reduce investment returns. There can be no assurance that an active trading market for Fund shares will be developed or maintained. The risks associated with the Fund are detailed in the prospectus and could include factors such as market risk, active management risk, blockchain technology risk, non-blockchain technology business line risk, foreign issuer exposure risk, emerging markets risk, depositary receipt risk, currency risk, large capitalization risk, cryptocurrency markets risk, investment style risk, small-capitalization and mid-capitalization securities risk, geographic focus risk, financials sector risk, technology sector risk, authorized participants, market makers and liquidity providers concentration risk, cash redemption risk, market trading risk, liquidity risk, valuation risk and portfolio turnover risk.

NOT FDIC INSURED | MAY LOSE VALUE | NOT BANK GUARANTEED

Distributor: Foreside Financial Services, LLC, member FINRA, SIPC
Contact
Scott Freeze
CEO – SRN Advisors, LLC
855-713-3837
sfreeze@srnadvisors.com

Cision View original content:https://www.prnewswire.com/news-releases/srn-advisors-llc-announces-changes-to-investment-objective-principal-investment-strategies-and-name-for-the-siren-nasdaq-nexgen-economy-etf-blcn-302647004.html

SOURCE Siren ETF Trust

Cision PR Newswire

Cision PR Newswire

Related Posts

Innovent Announces Expansion of Global Phase 3 MarsLight-11 Study of IBI363/TAK-928 (Alpha-biased IL-2/PD-1 Bispecific Fusion Protein) in Immunotherapy-Resistant NSCLC to Include Patients with Non-Squamous NSCLC

September 28, 2026

SEEKOUT Moves Beyond Japan into North America and Europe, Accelerating Global Push in Premium Pet Market

September 28, 2026

PAINSTUDY Inc. Targets ‘Self-Medication’ Demand with Functional Muscle and Joint Patches

September 28, 2026

SMPL Deadline: SMPL Investors Have Opportunity to Lead The Simply Good Foods Company Securities Fraud Lawsuit

September 27, 2026

Cuvo Health Publishes 2026 State-by-State Virtual Clinic Compliance Report: 33 of 51 Jurisdictions Restrict the Corporate Practice of Medicine

September 27, 2026

Global Running Boom Takes Center Stage at Sold-Out Life Time Chicago Half Marathon & 5K

September 27, 2026

Popular News

  • PAINSTUDY Inc. Targets ‘Self-Medication’ Demand with Functional Muscle and Joint Patches

    0 shares
    Share 0 Tweet 0
  • SEEKOUT Moves Beyond Japan into North America and Europe, Accelerating Global Push in Premium Pet Market

    0 shares
    Share 0 Tweet 0
  • Innovent Announces Expansion of Global Phase 3 MarsLight-11 Study of IBI363/TAK-928 (Alpha-biased IL-2/PD-1 Bispecific Fusion Protein) in Immunotherapy-Resistant NSCLC to Include Patients with Non-Squamous NSCLC

    0 shares
    Share 0 Tweet 0
  • SMPL Deadline: SMPL Investors Have Opportunity to Lead The Simply Good Foods Company Securities Fraud Lawsuit

    0 shares
    Share 0 Tweet 0
  • Cuvo Health Publishes 2026 State-by-State Virtual Clinic Compliance Report: 33 of 51 Jurisdictions Restrict the Corporate Practice of Medicine

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler